Written by: the Medetone Medical Team
Medically reviewed by: Dr Abdullah
Reading time: 6 minutes · Guidance verified: October 2026
Mounjaro Experiences in Germany and Medetone Customer Reviews
Most people in Germany searching for Mounjaro experiences are not looking for a product description. They want to know when hunger actually changes, when the scale moves, why week eight stalls, and whether what they are feeling is normal. This guide answers that from the mechanism up, because nearly every commonly reported experience has a physiological explanation behind it. It is written for patients in Germany and is informational only, so it does not replace advice from your doctor. For the underlying pharmacology, see our guide to how Mounjaro works, and for clinical detail on the treatment itself, Mounjaro.
Alongside our guide to Mounjaro experiences, we share three named Medetone Trustpilot reviews from customers in Germany, covering delivery, the ordering and review process, and support with questions. Their comments help illustrate the service experience without making claims about treatment outcomes.
The essentials
-
Appetite changes first, usually within days
-
A clear weight trend typically appears between weeks 4 and 8
-
Progress is not linear, and early fluctuation is expected
-
A plateau is rarely a sign the treatment has stopped working
-
The highest dose is not the goal, the lowest effective dose is
-
In Germany, weight-management medicines are self-pay, which makes dose decisions matter
Medetone Trustpilot reviews from customers in Germany
When choosing a treatment provider, the experience of ordering, receiving delivery and getting answers matters too. These three Medetone reviews describe those practical parts of our service. The original comments below are in German.
5 out of 5 stars · Verified review · Published 8 October 2026
Date of experience: 5 October 2026
“Fast, uncomplicated delivery.”
Elvira’s comment focuses on a straightforward delivery experience. For readers considering our service, it offers a specific customer perspective on receiving an order.
Read Elvira Drygala’s original Medetone review on Trustpilot.
Philipp on ordering and the review process
5 out of 5 stars · Verified review · Published 17 September 2026
Date of experience: 7 September 2026
“Simple ordering and review process. Always punctual delivery.”
Philipp highlights both the ordering process and delivery timing. His comment describes how he experienced the service; a straightforward process still includes the checks needed before treatment can be prescribed.
Read Philipp’s original Medetone review on Trustpilot.
N. on delivery and support with questions
5 out of 5 stars · Unprompted review · Published 8 June 2026
Date of experience: 8 June 2026
“Perfect in every area, fast delivery, great support with all questions, excellent product 🌺”
N. particularly praises the support available for questions, alongside delivery and overall satisfaction. The review does not name the product, so we do not attribute that product comment to Mounjaro.
Read N.’s original Medetone review on Trustpilot.
These are three selected customer experiences, not a summary of every review or a guarantee of the same experience for everyone. Elvira’s and Philipp’s reviews carry a verified label; N.’s is labelled unprompted. Clinical suitability, side effects and expected treatment outcomes should be discussed separately with your prescriber.
Mounjaro experiences in week 1: why hunger changes before the scale does
Tirzepatide acts on two receptors at once, GIP and GLP-1. That dual action is why the early experience is so consistent across patients.
Through the GLP-1 pathway, gastric emptying slows. Food stays in the stomach longer, so fullness arrives earlier in a meal and lasts longer after it. At the same time, appetite signalling in the hypothalamus is dampened, which is what most people describe as the background chatter about food going quiet. Insulin release is also enhanced in a glucose-dependent way, so it responds to what you eat rather than running constantly.
The GIP pathway adds a second signal affecting appetite and how energy is handled in fat tissue, and is thought to improve tolerability compared with a single-pathway treatment.
The practical consequence matters: portion size falls within days, but fat loss is a slower downstream result of that reduced intake. A week one with no movement on the scale is not failure. It is the expected sequence.
Mounjaro experiences week by week, from week 1 to week 12
|
Period |
What is happening physiologically |
What patients commonly report |
What it is often mistaken for |
|---|---|---|---|
|
Weeks 1 to 2 |
Slowed gastric emptying, reduced appetite signalling |
Less hunger, earlier fullness, smaller portions |
“It is not working, the scale has not moved” |
|
Weeks 3 to 4 |
Intake stabilises at a lower level |
Calmer eating pattern, fewer cravings |
“I must need a higher dose now” |
|
Weeks 5 to 8 |
Sustained energy deficit becomes visible |
Clearer downward weight trend |
“This rate will continue indefinitely” |
|
Weeks 9 to 12 |
Metabolic and behavioural adaptation begins |
Plateau or a stable routine |
“The treatment has stopped working” |
Our guide on how long Mounjaro takes to work covers the evidence behind this timeline in more detail.
Why Mounjaro experiences in Germany are rarely linear
Three things create the fluctuation patients find so unsettling.
Water and glycogen shift first. Reducing carbohydrate intake releases stored glycogen and the water bound to it, which can show as a fast early drop followed by an apparent stall. Neither number is fat.
Dose steps reset tolerability. Each increase can temporarily affect appetite, digestion and fluid intake, so the week after a step up rarely looks like the week before it.
Measurement noise is real. Salt, hydration, the menstrual cycle, training load and bowel habit can move the scale by one to two kilograms in either direction without any change in body composition. Weekly averages tell the truth that daily readings hide.
The dose question: why many patients in Germany need less than they expect
This is where most people go wrong. The objective is not the highest tolerated dose, it is the lowest dose that produces adequate appetite reduction and is comfortable to live with.
This carries particular weight in Germany. Weight-management medicines are classed as lifestyle medicines under section 34 of the Social Code Book V, so statutory health insurance does not cover them and treatment is self-funded. A dose that is higher than you need therefore costs more and is tolerated less well, with no better outcome.
If hunger is already controlled, portions are smaller and weight is trending down, there is often no clinical reason to escalate immediately. Our guide to Mounjaro dosing and titration explains how escalation decisions are normally made. Dose changes should always be a clinical decision, never a reaction to one slow week.
Mounjaro experiences with a plateau: what is actually happening
A plateau is predictable, and it usually has four contributors rather than one.
Energy expenditure falls as body mass falls, because a lighter body costs less to move. Non-exercise activity drops quietly, so daily step count and general movement decline without being noticed. Protein intake often falls with total intake, which puts lean mass at risk. And liquid calories creep back in because they bypass the fullness mechanism almost entirely.
The fix is rarely more milligrams. Protein of roughly 25 to 35 g per meal, two to three resistance sessions a week, and honest tracking of drinks address the actual cause. See our guide to protein on Mounjaro for practical targets.
Body composition also explains why the scale misleads. If fat mass falls while muscle is preserved, weight can hold steady while the result is genuinely good.
Tolerability: what is normal and what is not
Nausea, early fullness, constipation and mild fatigue are the most frequently reported effects, usually in the first weeks and after each dose step. They generally settle.
What should not be tolerated quietly: symptoms that worsen rather than settle, inability to take in adequate fluid, severe or persistent abdominal pain, or dizziness and weakness that interfere with daily life. Those warrant clinical review rather than waiting it out.
What to check before you start in Germany
Three things are worth confirming with any service operating in the German market.
Pricing is visible before you commit. Our treatment costs are shown openly on the product page rather than appearing only after an assessment.
There is no separate consultation fee. Some services add an assessment charge on top of treatment. Our clinical review is included.
Every order is reviewed by an EU-registered clinician. We are an EU-registered pharmacy delivering to German addresses, and no treatment is approved without an individual clinical assessment of your history, medicines and suitability.
Accessing care in Germany and beyond
Patients in Germany can review the full range of weight-loss treatments and complete a clinical assessment with us. Patients in France can do the same at medetone.com/fr.
In the United Kingdom, care is available through uk.medetone.com and our partner service rightangled.com. In the United States, patients can access treatment through us.medetone.com.
When to speak to a doctor
Book a review if weight has stagnated for several weeks alongside fatigue or weakness, if side effects are worsening instead of settling, if you cannot maintain fluid or protein intake, or if you are unsure whether your current dose is appropriate.
Frequently asked questions about Mounjaro experiences in Germany
When does Mounjaro start working?
Appetite usually changes within the first one to two weeks. A clearer weight trend typically appears between weeks 4 and 8.
Why has nothing happened on the scale in week 1?
Because appetite reduction comes first and fat loss follows it. Week one changes how you eat, not usually what you weigh.
Does a plateau mean it has stopped working?
Rarely. Falling energy expenditure, reduced daily movement, low protein and liquid calories explain most plateaus.
Is a low dose enough for some patients?
For some, yes. The clinically relevant target is the lowest dose that is effective and well tolerated.
Does statutory health insurance in Germany cover it?
No. Weight-management medicines are excluded as lifestyle medicines, so treatment is self-funded.
Do Medetone’s Trustpilot reviews show how much weight I could lose?
No. The three reviews featured here describe delivery, ordering and support. They do not identify Mounjaro or report weight loss. Your response to treatment requires individual clinical assessment.
What happens if I stop?
Appetite signalling returns to baseline, so hunger increases. Structure, protein and resistance training become more important.
In summary
The Medetone reviews featured above give specific customer perspectives on delivery, ordering and support. Read them alongside medical information when considering our service, and use a consultation to discuss whether treatment is appropriate for you.
Mounjaro experiences reported by patients in Germany follow a consistent pattern because the mechanism is consistent. Dual GIP and GLP-1 action slows gastric emptying and reduces appetite signalling, so eating changes within days while the scale follows weeks later. Progress fluctuates for reasons that have nothing to do with the treatment failing, and plateaus usually reflect adaptation, lost daily movement and low protein rather than an insufficient dose. Because treatment is self-funded in Germany, the lowest effective dose matters more here than almost anywhere. Clinical supervision is what turns scattered Mounjaro experiences into a decision that fits you.
Medical information: this article is for information only and does not replace diagnosis or medical advice. Speak to your doctor or pharmacist about your individual situation.
References:
European Medicines Agency, Mounjaro product information: https://www.ema.europa.eu
BfArM, Bundesinstitut für Arzneimittel und Medizinprodukte: https://www.bfarm.de
Gemeinsamer Bundesausschuss: https://www.g-ba.de
Robert Koch-Institut: https://www.rki.de
World Health Organization, Obesity and overweight: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Customer review references:
-
Elvira Drygala. “Schnelle unkomplizierte Lieferung.” Trustpilot, 8 October 2026. Original review.
-
Philipp. “Einfacher Bestell- und Prüfprozess.” Trustpilot, 17 September 2026. Original review.
-
N. “Perfekt in allen Bereichen.” Trustpilot, 8 June 2026. Original review.
